Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Diabetes, Autoimmune: early-phase trial registry

2 of 3 indexed Diabetes, Autoimmune trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Diabetes, Autoimmune: 3 US clinical trials tracked, 2 recruiting.

Diabetes, Autoimmune is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 2 of these trials.

Enrollment posture brief

Registry condition diabetes-autoimmune

OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 2

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Diabetes, Autoimmune (this)67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Diabetes, Autoimmune

Diabetes, Autoimmune lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diabetes, Autoimmune on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diabetes, Autoimmune is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Diabetes, Autoimmune records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Starbucks® Cold brew - 325ml bottle Drug
1 trials
Bionic Pancreas Device
1 trials
Routine Care Other
1 trials
TakeCharge Behavioral
1 trials
ReCharge Behavioral
1 trials

US sites by state

Facility locations filed on Diabetes, Autoimmune trials. A trial with sites in several states counts in each.

Colorado 2 trials
North Carolina 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diabetes, Autoimmune page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes, Autoimmune condition card totals 3 registered trials; most-linked intervention Starbucks® Cold brew - 325ml bottle; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.